NasdaqCM - Delayed Quote USD
Cognition Therapeutics, Inc. (CGTX)
0.3011
-0.0289
(-8.76%)
At close: May 9 at 4:00:00 PM EDT
0.3901
+0.09
+(29.56%)
After hours: May 9 at 7:59:59 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 3 |
| Avg. Estimate | -0.06 | -0.12 | -0.43 | -0.31 |
| Low Estimate | -0.06 | -0.12 | -0.44 | -0.35 |
| High Estimate | -0.06 | -0.12 | -0.41 | -0.28 |
| Year Ago EPS | -0.18 | -0.25 | -0.86 | -0.43 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.23 | -0.21 | -0.15 | -0.12 |
| EPS Actual | -0.18 | -0.25 | -0.17 | -0.14 |
| Difference | 0.05 | -0.04 | -0.02 | -0.03 |
| Surprise % | 23.08% | -17.19% | -11.48% | -21.74% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.06 | -0.12 | -0.43 | -0.31 |
| 7 Days Ago | -0.1 | -0.1 | -0.4 | -0.26 |
| 30 Days Ago | -0.1 | -0.1 | -0.4 | -0.26 |
| 60 Days Ago | -0.14 | -0.2 | -0.62 | 0 |
| 90 Days Ago | -0.14 | -0.2 | -0.62 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 3 | 1 |
| Up Last 30 Days | 2 | 2 | 3 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CGTX | 66.67% | 52.00% | 50.00% | 28.68% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 5/8/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/21/2025 |
| Maintains | Chardan Capital: Buy to Buy | 2/26/2025 |
| Upgrade | B. Riley Securities: Neutral to Buy | 12/19/2024 |
| Maintains | Chardan Capital: Buy to Buy | 12/19/2024 |
Related Tickers
AVXL Anavex Life Sciences Corp.
8.25
-3.62%
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
TNFA TNF Pharmaceuticals, Inc.
0.1900
-3.36%
GRI GRI Bio, Inc.
1.4700
-8.12%
ZVSA ZyVersa Therapeutics, Inc.
0.5272
-7.70%
IRD Opus Genetics, Inc.
0.9468
-4.92%
TOVX Theriva Biologics, Inc.
0.5299
-17.61%
PHIO Phio Pharmaceuticals Corp.
1.7600
-2.22%
CDT Conduit Pharmaceuticals Inc.
0.4000
0.00%
SPRC SciSparc Ltd.
0.3443
+0.53%